Abstract:Background: The respiratory system, traditionally considered antiseptic, harbors a diverse and dynamic bacterial microbiome. Recent advancements in microbiome research have revealed its significant influence on both innate and adaptive immunity, particularly in the context of respiratory infections in children. This article also provides an overview of the types of bacteria that commonly affect the respiratory system, including Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. These bacteria are prevalent in pediatric populations and significantly contribute to the development and severity of respiratory tract infections (RTIs). Purpose: This review aims to evaluate the impact of the oral cavity and upper respiratory microbiome on the susceptibility and severity of respiratory infections in pediatric populations. We specifically focus on how early colonization patterns of bacteria such as Moraxella and Streptococcus contribute to the development of respiratory tract infections in children from birth through adolescence. Methods: A thorough literature review was performed, focusing on studies publishing between 2004 and 2023. The review included research exploring the role of the upper respiratory microbiome in pediatric populations, with a specific focus on children aged birth to 18 years. Emphasis was placed on microbial characterization, the modulation of immune responses in respiratory tract infections, and the potential therapeutic applications of microbiome-targeted interventions. Results: The findings suggest that the composition and disruption of the upper respiratory microbiome significantly influence clinical outcomes in children with respiratory infections. Notably, dysbiosis in the microbiome has been linked to increased susceptibility to repeated infections, highlighting the importance of maintaining microbial balance for optimal respiratory health. Conclusion: Understanding the impact of oral cavity and upper respiratory microbiome could lead to improved management and prevention strategies for respiratory infections in children. This review underscores the potential of microbiome modulation, including the use of probiotics as a therapeutic approach to enhance clinical outcomes in pediatric respiratory infections.

A clinicians' review of the respiratory microbiome

The Human Respiratory Microbiome: Current Understandings and Future Directions

The Lower Airway Microbiome in Paediatric Health and Chronic Disease

Targeting respiratory microbiomes in COPD and bronchiectasis

The Lung Microbiome

The lung microbiome: clinical and therapeutic implications

The role of oral microbiome in respiratory health and diseases

The microbiome in bronchiectasis

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

Lung microbiome: new insights into the pathogenesis of respiratory diseases

Environmental exposures, the oral–lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function

Lung microbiota and potential treatment of respiratory diseases

The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract

Microbiome effects on immunity, health and disease in the lung

Oral Cavity Microbiome Impact on Respiratory Infections Among Children

The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease

The gut microbiome in health and in disease

The dynamic lung microbiome in health and disease

The microbiome of the upper respiratory tract in health and disease

The association between the respiratory tract microbiome and clinical outcomes in patients with COPD